Study Title (official): BRCA Founder Outreach (BFOR) Study
Objective of the study (Lay terms): The BRCA Founder Outreach (BFOR) Study is a new research initiative. It will pioneer new ways to integrate genetic testing into medical care. This model combines the convenience of direct-to-consumer genetic tests along with the advantages of receiving testing with the guidance of a medical care provider.
BFOR seeks to increase access to testing for one of the most common tests for hereditary cancer, BRCA genetic mutations. These mutations of BRCA genes are associated with greater risks for several types of cancer, including breast, ovarian, and prostate cancer.
BFOR will provide patients, families, and their doctors with better information to make important decisions about their health care. This information will help thousands of people to reduce their cancer risks.
The study will offer women and men of Ashkenazi Jewish (Eastern European) ancestry, age 25 or older, genetic testing for common BRCA mutations. This group is at least ten times more likely than the general population to inherit certain kinds of BRCA mutations. Participants must meet the following criteria:
Principal Investigator: Beth Karlan, MD
Department: UCLA Department of OBGYN
For enrollment or criteria information:
For additional information regarding inclusion and exclusion criteria > ClinicalTrials.gov